Brain PET in the diagnosis of Alzheimer's disease.
Publication
, Journal Article
Marcus, C; Mena, E; Subramaniam, RM
Published in: Clin Nucl Med
October 2014
OBJECTIVES: The aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET can help in differentiating Alzheimer's disease from other causes of dementia such as frontotemporal dementia and dementia of Lewy body. Amyloid brain PET may exclude significant amyloid deposition and thus Alzheimer's disease in appropriate clinical setting. CONCLUSIONS: FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
October 2014
Volume
39
Issue
10
Start / End Page
e413 / e422
Location
United States
Related Subject Headings
- Radiopharmaceuticals
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Lewy Body Disease
- Humans
- Frontotemporal Dementia
- Cognitive Dysfunction
- Brain
- Alzheimer Disease
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Marcus, C., Mena, E., & Subramaniam, R. M. (2014). Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med, 39(10), e413–e422. https://doi.org/10.1097/RLU.0000000000000547
Marcus, Charles, Esther Mena, and Rathan M. Subramaniam. “Brain PET in the diagnosis of Alzheimer's disease.” Clin Nucl Med 39, no. 10 (October 2014): e413–22. https://doi.org/10.1097/RLU.0000000000000547.
Marcus C, Mena E, Subramaniam RM. Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med. 2014 Oct;39(10):e413–22.
Marcus, Charles, et al. “Brain PET in the diagnosis of Alzheimer's disease.” Clin Nucl Med, vol. 39, no. 10, Oct. 2014, pp. e413–22. Pubmed, doi:10.1097/RLU.0000000000000547.
Marcus C, Mena E, Subramaniam RM. Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med. 2014 Oct;39(10):e413–e422.
Published In
Clin Nucl Med
DOI
EISSN
1536-0229
Publication Date
October 2014
Volume
39
Issue
10
Start / End Page
e413 / e422
Location
United States
Related Subject Headings
- Radiopharmaceuticals
- Positron-Emission Tomography
- Nuclear Medicine & Medical Imaging
- Lewy Body Disease
- Humans
- Frontotemporal Dementia
- Cognitive Dysfunction
- Brain
- Alzheimer Disease
- 3202 Clinical sciences